| Literature DB >> 30159099 |
Daqiang Ke1, Feng Zhou1, Hui Liang1, Yang Xu2, Haiyan Lou3.
Abstract
Intracranial hemorrhage or microbleeds and leukoaraiosis have an overlap in biology. Hyperlipidemia may reduce the risk of ICH or cerebral microbleeds; studies focusing on the relationship between different lipid profiles and severity of periventricular hyperintensities (PVH) and subcortical white matter lesions (SWMLs) in the cerebral small vessel disease are limited. Methods. Patients with recent first lacunar infarct were recruited. PVH and SWMLs were accessed on MRI with the Fazekas scale, and lipid levels were measured. Univariate and multivariable regression analyses were used to assess the relation between different lipid profiles and severity of PVH and SWMLs. Results. In univariate analyses, advancing age was correlated with increasing severity of leukoaraiosis (P < 0.001). There was an inverse relationship between hypertriglyceridemia (hyper-TG) (≥1.7 mmol/l) and severity of leukoaraiosis (P < 0.05). In the multivariable analysis, after controlling for age, sex, and significant risk factors in the univariate and age-adjusted analyses, hyper-TG demonstrated a protective effect on the severity of PVH and SWMLs (P < 0.05). Higher total cholesterol (TC), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were not associated with leukoaraiosis. Conclusions. Hyper-TG is associated with the severity of leukoaraiosis independent of other risk factors, and it might be a protective role in cerebral small vessel disease.Entities:
Mesh:
Year: 2018 PMID: 30159099 PMCID: PMC6109573 DOI: 10.1155/2018/1361780
Source DB: PubMed Journal: Behav Neurol ISSN: 0953-4180 Impact factor: 3.342
Demographic characteristics of patients according to the severity of leukoaraiosis.
| PVH | SWMLs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 |
| 0 | 1 | 2 | 3 |
| |
| Age, y | 52 (4.8) | 63.2 (0.6) | 71 (10.1) | 75.2 (8.8) | <0.001 | 58.3 (9.5) | 68.8 (10.7) | 72.6 (9.4) | 74.3 (10) | <0.001 |
| Sex, female | 21.4 | 37.7 | 32.4 | 34.7 | 0.684 | 24 | 28.8 | 33.3 | 31.6 | 0.768 |
| DM | 28.6 | 27.5 | 31.1 | 26.5 | 0.948 | 22.0 | 28.8 | 35.6 | 28.9 | 0.545 |
| HTN | 78.6 | 71.0 | 67.6 | 81.6 | 0.347 | 70.0 | 60.3 | 84.4 | 86.8 | 0.005 |
| CHD | 7.1 | 4.30 | 4.1 | 8.2 | 0.744 | 4.0 | 4.1 | 11.1 | 2.6 | 0.271 |
| Smoking | 42.9 | 43.5 | 41.9 | 30.6 | 0.511 | 36 | 41.1 | 46.7 | 34.2 | 0.63 |
| Taking statins | 7.1 | 5.8 | 6.8 | 10.9 | 0.738 | 6 | 6.8 | 4.4 | 15.8 | 0.22 |
| Higher TG | 57.1 | 39.1 | 28.4 | 16.3 | 0.008 | 50 | 30.1 | 24.4 | 15.8 | 0.004 |
| Higher TC | 21.4 | 17.4 | 12.2 | 10.2 | 0.555 | 26 | 9.6 | 15.6 | 5.3 | 0.022 |
| Higher HDL | 57.1 | 55.1 | 56.8 | 61.2 | 0.928 | 50 | 60.3 | 53.3 | 65.8 | 0.43 |
| Higher LDL | 14.3 | 14.5 | 17.6 | 12.2 | 0.875 | 24 | 11 | 15.6 | 10.5 | 0.195 |
Severity of leukoaraiosis is measured according to the total score on the Fazekas scale. Age is represented by the mean of years (SD) in each subgroup. The other variables are represented by the percent of individuals who qualified for this variable in each subgroup. DM: diabetes mellitus; CHD: coronary heart disease; HTN: hypertension.
Distribution in serum lipid concentration according to the leukoaraiosis grade.
| PVH | SWMLs | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |
| TG | 2.58 ± 1.19 | 1.84 ± 0.8 | 1.47 ± 0.7 | 1.05 ± 0.6 | 248 ± 0.94 | 1.79 ± 0.77 | 1.39 ± 0.5 | 1.03. ± 0.51 |
| TC | 4.41 ± 1.08 | 4.51 ± 1.15 | 4.57 ± 1.13 | 4.47 ± 1.07 | 4.37 ± 0.88 | 4.38 ± 1.15 | 4.56 ± 1.08 | 4.66 ± 1.23 |
| HDL | 1.15 ± 0.31 | 1.17 ± 0.38 | 1.1 ± 0.28 | 1.04 ± 0.22 | 1.15 ± 0.27 | 1.17 ± 0.37 | 1.14 ± 0.34 | 1.08 ± 0.29 |
| LDL | 2.47 ± 0.8 | 2.52 ± 0.86 | 2.56 ± 0.77 | 2.35 ± 0.81 | 2.45 ± 0.71 | 2.42 ± 0.85 | 2.53 ± 0.77 | 2.59 ± 0.91 |
Associations between lipid profiles and severity of leukoaraiosis in multivariate models (adjustment for age).
| PVH | SWMLs | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Age | — | — | — | — | — | — |
| Sex | 1.06 | 0.53–2.1 | 0.877 | 1.39 | 0.71–2.73 | 0.338 |
| DM | 0.84 | 0.47–1.51 | 0.561 | 1.21 | 0.69–2.15 | 0.508 |
| HTN | 1.27 | 0.69–2.32 | 0.438 | 2.4 | 1.31–4.42 | 0.005 |
| CHD | 0.9 | 0.28–2.91 | 0.87 | 0.89 | 0.88–2.82 | 0.847 |
| Prior stroke | 6.01 | 2.8–12.91 | <0.001 | 3.42 | 1.69–6.94 | 0.001 |
| Smoking | 0.62 | 0.32–1.18 | 0.144 | 0.9 | 0.48–1.68 | 0.731 |
| Taking statins | 0.82 | 0.29–2.3 | 0.705 | 0.98 | 0.36–2.65 | 0.969 |
| TG ≥ 1.7 mmol/l versus <1.7 mmol/l | 0.34 | 0.19–0.63 | 0.001 | 0.37 | 0.2–0.67 | 0.001 |
| TC ≥ 5.18 mmol/l versus <5.18 mmol/l | 0.42 | 0.14–1.21 | 0.109 | 0.45 | 0.16–1.3 | 0.139 |
| HDL ≥ 2.04 mmol/l versus <2.04 mmol/l | 1.22 | 0.7–2.12 | 0.484 | 1.73 | 1.01–3 | 0.05 |
| LDL ≥ 3.37 mmol/l versus <3.37 mmol/l | 1.97 | 0.71–5.44 | 0.192 | 1.05 | 0.39–2.84 | 0.916 |
OR: odds ratio.
Associations between lipid profiles and severity of leukoaraiosis in multivariate models.
| PVH | SWMLs | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Age | 1.11 | 1.08–1.14 | <0.001 | 1.1 | 1.06–1.13 | <0.001 |
| Sex | 0.95 | 0.47–1.92 | 0.879 | 1.35 | 0.67–2.7 | 0.401 |
| DM | 0.84 | 0.46–1.54 | 0.565 | 1.29 | 0.71–2.32 | 0.401 |
| HTN | 1.09 | 0.58–2.04 | 0.795 | 2.32 | 1.24–4.34 | 0.009 |
| CHD | 0.6 | 0.17–2.09 | 0.419 | 0.58 | 0.17–1.93 | 0.373 |
| Smoking | 1.17 | 0.59–2.31 | 0.651 | 1.68 | 0.86–3.27 | 0.127 |
| Taking statins | 1.04 | 0.35–3.03 | 0.95 | 1.35 | 0.26–2.07 | 0.567 |
| TG ≥ 1.7 mmol/l versus <1.7 mmol/l | 0.49 | 0.26–0.93 | 0.029 | 0.49 | 0.48–3.7 | 0.027 |
| TC ≥ 5.18 mmol/l versus <5.18 mmol/l | 0.45 | 0.15–1.36 | 0.156 | 0.58 | 0.192–1.73 | 0.328 |
| HDL ≥ 2.04 mmol/l versus <2.04 mmol/l | 1.01 | 0.57–1.8 | 0.97 | 1.51 | 0.86–2.64 | 0.153 |
| LDL ≥ 3.37 mmol/l versus <3.37 mmol/l | 2.37 | 0.81–6.9 | 0.113 | 1.02 | 0.99–2.8 | 0.974 |
OR: odds ratio.